Another Notice For Comments On Kratom: Cue Second Wave Of Support For Botanical In US?

FDA states in Federal Register notice that WHO has requested information on whether kratom – mitragynine, 7-hydroxymitragynine – should be added to the United Nations’ schedule of controlled substances.

The US Food and Drug Administration isn’t the only public health agency concerned about the botanical kratom’s potential for abuse.

If a request for comment about kratom that the FDA is publishing for the World Health Organization generates a response even close to the response to the Drug Enforcement Administration’s 2016 request for comment

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation